KEEP BUT DO NOT DISPLAY

New Obesity Drug Now Available Eisai and Arena Pharmaceuticals’ obesity drug Belviq is now available in the U.S. Belviq (lorcaserin) is a 5HT2c-receptor agonist that promotes satiety after meals and reduces sensations of hunger before meals.

Data on 1,479 patients with type 2 diabetes and stable coronary disease revealed 24.1% of those who received insulin-providing medications to regulate blood glucose levels developed peripheral arterial disease at 4.6 years, compared with 16.9% in those who took insulin-sensitizing drugs. Researchers also found patients on insulin sensitizers showed reduced …

Using low-calorie sweeteners in place of sugar may help reduce increases in blood glucose levels and help prevent and manage type 2 diabetes. Researchers said artificial sweeteners may also aid in weight control, as they do not have the same negative effects on insulin and hormone levels as regular sugar. …

Researchers at the University of Pittsburgh have developed a breath test using a combination of titanium dioxide and carbon nanotubes that could serve as a noninvasive means of monitoring blood glucose levels. "Such a device could completely change the paradigm of self-monitoring diabetes," said principal investigator Alexander Star. 

On discovering that type 1 diabetes destroys blood vessels as well as insulin-producing cells, scientists at the University of Missouri have developed a drug called Ig-GAD2 that works with adult stem cells from bone marrow. Lead author Habib Zaghouani said, "The bone marrow cells led to growth of new blood …

Sticking to a Nordic diet plan — rich in berries, fish, and canola oil — lowered cholesterol and inflammation in people with metabolic syndrome, much like the better-known Mediterranean diet. Researchers from Finland, Sweden, Denmark and Iceland said the next step is to see whether the diet can be used …

A report by the United Health Foundation revealed Michigan had the highest number of obese seniors at 29.5%, while Hawaii had the lowest rate at 16.9% among those ages 65 and older. Researchers also found seniors in Minnesota were the healthiest in the nation. Detroit Free Press 

An innovative new shoe could significantly reduce the number of diabetic foot amputations from inadequate blood flow by replicating the pumping mechanism of the body’s circulatory system. Pulseboot, which was developed in the U.K., is drawing interest in a number of other countries, including the U.S. The design, created five …

Doctor-patient communication that leads to medical decision-making needs improvement, according to four studies and a commentary published in JAMA Internal Medicine. Patient surveys found physicians did not always discuss risks and benefits of treatments or screenings, patient prognosis, or eligibility for transplants. Data showed some patients wanted information and control …

The independent panel of national experts also said in the new draft recommendation statement that there is not enough evidence to weigh the benefits and risks of screening for diabetes that develops during pregnancy before 24 weeks. "It’s important to remember that each case of gestational diabetes affects two people: …